Januglutide Tablet 100 Milligrams (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
MFDS item code 202004036 · Approved 2020.05.29
This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement in blood sugar control in type 2 diabetes
This medication is used to assist in blood sugar control for patients with type 2 diabetes, in conjunction with diet and exercise therapy. It can be administered alone, and in cases where blood sugar control is challenging with monotherapy at the initial treatment stage, it may be used in combination with metformin. Additionally, when sufficient blood sugar control is not achieved with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be used in combination therapy. If blood sugar control remains difficult with combination therapy, adding sitagliptin may increase treatment efficacy. This medication helps in diabetes management through effective blood sugar control.
The recommended adult dosage for this medication is 100 mg of sitagliptin administered once daily either as monotherapy or in combination therapy, with a maximum daily dosage of 100 mg. It can be taken regardless of meals. Patients with renal impairment may require dosage adjustments based on renal function. In patients with mild to moderate renal impairment, dosage adjustments are not necessary. For patients with a glomerular filtration rate of 30-45 mL/min/1.73 m², the dosage is 50 mg once daily.
This medication may cause allergic reactions; therefore, if symptoms such as skin rash or difficulty in breathing occur, it should be discontinued immediately, and a doctor consulted. If symptoms of acute pancreatitis, such as severe abdominal pain, vomiting, or fever, occur during the course of taking this medication, medical personnel should be notified immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with impaired kidney function may need dosage adjustment for this medication, so regular kidney function tests should be conducted. This medication may increase the risk of hypoglycemia when taken with other blood glucose-lowering agents, particularly insulin or sulfonylureas, so caution is advised, and dose adjustments of other medications may be necessary if needed. If symptoms of severe joint pain or skin blistering occur, the medication should be stopped immediately, and a doctor consulted. Pregnant or breastfeeding women are advised to avoid using this medication. This medication may also be used in the elderly, but dosage adjustments should be made considering decreased kidney function, and regular check-ups are necessary. In cases of overdose, general emergency procedures should be followed, and blood dialysis may be done if necessary. Some patients may experience side effects such as dyspepsia, headache, upper respiratory tract infection, so if abnormal symptoms persist, they should inform medical personnel.
Hives, severe swelling (angioedema), anaphylaxis, severe skin reactions (Stevens-Johnson syndrome, rash, vasculitis, exfoliative dermatitis), acute pancreatitis, liver abnormalities (elevated liver enzymes, potential jaundice), acute kidney failure, severe joint pain accompanied by disabilities, bullous pemphigoid, rhabdomyolysis, cardiac arrest, pneumonia, diabetes complications, metabolic acidosis, severe hypoglycemia, severe neurological symptoms (seizures, alteration of consciousness)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that is well-ventilated, and kept in an environment maintaining room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness and safety of the medication.
Light orange, round, bilayer concave film-coated tablet
28 Tablets/PVC [14 Tablets/PVC * 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.